Literature DB >> 23414861

Surgical treatment and outcomes of severe pediatric intestinal motility disorders requiring parenteral nutrition.

Mikko P Pakarinen1, Annika Kurvinen, Antti I Koivusalo, Tarja Ruuska, Heikki Mäkisalo, Hannu Jalanko, Risto J Rintala.   

Abstract

AIM: The aim of this study was to characterize outcomes of children with severe intestinal motility disorders (IMD) requiring parenteral nutrition (PN).
METHODS: Twenty consecutive children with primary IMD requiring long-term PN between 1984 and 2010 were included. Median (interquartile range) follow-up was 13.1 (5.2-20.1) years. Treatment, PN dependence, growth, nutritional status, liver function, and survival were assessed.
RESULTS: Underlying etiology included chronic intestinal pseudo obstruction (CIPO; n=8) and Hirschsprung disease with extensive aganglionosis (n=12). CIPO and aganglionosis patients had 100 (86-100%) and 29 (19-40%) of age-adjusted small bowel length remaining, respectively. In order to facilitate enteral tolerance and avoid PN-associated liver disease, short aganglionic segment (40 cm) was left in situ in four of five cases, with aganglionosis extending to duodenojejunal flexure combined with Ziegler myectomy-myotomy in two. Six of seven children with aganglionosis extending into mid small intestine underwent staged jejunoanal pull-through. Feeding/venting gastrostomies (n=13) or jejunostomies were commonly employed. Probability of PN dependence owing to IMD was markedly increased in relation to short bowel syndrome (70 versus 19% at 5 years, P<0.0001). Two (10%) patients developed end-stage liver disease. A total of 11 (55%) patients (5 CIPO and 6 aganglionosis) weaned off PN after 8.2 years (1.8-17 years), including two patients after intestinal transplantation (ITx). Two children died before ITx-era giving overall survival of 90%. Survivors had well-preserved liver function, growth, and nutritional status.
CONCLUSIONS: Despite high PN dependence, long-term survival is achievable in the majority of children with IMD requiring PN. A wide repertory of surgical options including ITx is required for optimal outcomes.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23414861     DOI: 10.1016/j.jpedsurg.2012.11.010

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  7 in total

Review 1.  Autologous intestinal reconstruction surgery as part of comprehensive management of intestinal failure.

Authors:  Mikko P Pakarinen
Journal:  Pediatr Surg Int       Date:  2015-03-29       Impact factor: 1.827

2.  Nationwide survey of outcome in patients with extensive aganglionosis in Japan.

Authors:  Satoshi Obata; Satoshi Ieiri; Takashi Akiyama; Naoto Urushihara; Hisayoshi Kawahara; Masayuki Kubota; Miyuki Kono; Yuji Nirasawa; Shohei Honda; Masaki Nio; Tomoaki Taguchi
Journal:  Pediatr Surg Int       Date:  2019-03-07       Impact factor: 1.827

3.  A meta-analysis of clinical outcome of intestinal transplantation in patients with total intestinal aganglionosis.

Authors:  Hiroki Nakamura; Davina Henderson; Prem Puri
Journal:  Pediatr Surg Int       Date:  2017-06-09       Impact factor: 1.827

4.  Challenges in management and prognosis of pediatric intestinal pseudo-obstruction.

Authors:  Özlem Boybeyi Türer; Tutku Soyer; Hasan Özen; Umut Ece Arslan; İbrahim Karnak; Feridun Cahit Tanyel
Journal:  Turk J Gastroenterol       Date:  2020-08       Impact factor: 1.852

Review 5.  Paediatric intestinal pseudo-obstruction: a scoping review.

Authors:  Susan Nham; Alexander T M Nguyen; Andrew J A Holland
Journal:  Eur J Pediatr       Date:  2022-04-28       Impact factor: 3.860

6.  Ileostomy Prolapse in Children with Intestinal Dysmotility.

Authors:  Eric A Sparks; Cristine S Velazco; Brenna S Fullerton; Jeremy G Fisher; Faraz A Khan; Amber M Hall; Tom Jaksic; Leonel Rodriguez; Biren P Modi
Journal:  Gastroenterol Res Pract       Date:  2017-09-18       Impact factor: 2.260

7.  Causes and prognosis of chronic intestinal pseudo-obstruction in 48 subjects: A 10-year retrospective case series.

Authors:  Wei Lu; Yongtao Xiao; Jianhu Huang; Lina Lu; Yiqing Tao; Weihui Yan; Yi Cao; Wei Cai
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.